164 related articles for article (PubMed ID: 35557512)
1. Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers: A pilot study.
Gunady EF; Ware KE; Hoskinson Plumlee S; Devos N; Corcoran D; Prinz J; Misetic H; Ciccarelli FD; Harrison TM; Thorne JL; Schopler R; Everitt JI; Eward WC; Somarelli JA
Evol Med Public Health; 2022; 10(1):221-230. PubMed ID: 35557512
[TBL] [Abstract][Full Text] [Related]
2. Targeted and exome sequencing identified somatic mutations in hepatocellular carcinoma.
Hirotsu Y; Zheng TH; Amemiya K; Mochizuki H; Guleng B; Omata M
Hepatol Res; 2016 Oct; 46(11):1145-1151. PubMed ID: 26850916
[TBL] [Abstract][Full Text] [Related]
3. Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.
Wang S; Shi H; Liu T; Li M; Zhou S; Qiu X; Wang Z; Hu W; Guo W; Chen X; Guo H; Shi X; Shi J; Zang Y; Cao J; Wu L
Hepatobiliary Surg Nutr; 2021 Apr; 10(2):172-179. PubMed ID: 33898558
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous hepatocellular carcinoma in captive prosimians.
Zadrozny LM; Williams CV; Remick AK; Cullen JM
Vet Pathol; 2010 Mar; 47(2):306-11. PubMed ID: 20147584
[TBL] [Abstract][Full Text] [Related]
5. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
[TBL] [Abstract][Full Text] [Related]
6. Computational analysis of TP53 vs. CTNNB1 mutations in hepatocellular carcinoma suggests distinct cancer subtypes with differential gene expression profiles and chromatin states.
Biterge Süt B
Comput Biol Chem; 2020 Dec; 89():107404. PubMed ID: 33096424
[TBL] [Abstract][Full Text] [Related]
7. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous neoplasms in captive red-bellied lemurs (Eulemur rubriventer).
Barrantes Murillo DF; Negrão Watanabe TT
J Comp Pathol; 2023 Feb; 201():33-36. PubMed ID: 36680815
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
10. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
11. Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma.
Li L; Rao X; Wen Z; Ding X; Wang X; Xu W; Meng C; Yi Y; Guan Y; Chen Y; Wang J; Jun L
Oncol Lett; 2020 Apr; 19(4):2739-2748. PubMed ID: 32218826
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.
Zhang Y; Qiu Z; Wei L; Tang R; Lian B; Zhao Y; He X; Xie L
PLoS One; 2014; 9(7):e100854. PubMed ID: 24988079
[TBL] [Abstract][Full Text] [Related]
13. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
[TBL] [Abstract][Full Text] [Related]
14. H-ras consensus sequence and mutations in primary hepatocellular carcinomas of lemurs and lorises.
Cullen JM; Williams C; Zadrozny L; Otstot JT; Solomon GG; Sills RC; Hong HH
Vet Pathol; 2011 Jul; 48(4):868-74. PubMed ID: 21123858
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract][Full Text] [Related]
16. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
Fojo T; Huff L; Litman T; Im K; Edgerly M; Del Rivero J; Pittaluga S; Merino M; Bates SE; Dean M
BMC Med Genomics; 2020 Nov; 13(1):165. PubMed ID: 33148256
[TBL] [Abstract][Full Text] [Related]
17.
Wang L; Yan K; He X; Zhu H; Song J; Chen S; Cai S; Zhao Y; Wang L
J Cancer; 2021; 12(1):217-223. PubMed ID: 33391418
[No Abstract] [Full Text] [Related]
18. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.
Vilarinho S; Erson-Omay EZ; Mitchell-Richards K; Cha C; Nelson-Williams C; Harmancı AS; Yasuno K; Günel M; Taddei TH
J Hepatol; 2017 Jul; 67(1):186-191. PubMed ID: 28323122
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Schulze K; Imbeaud S; Letouzé E; Alexandrov LB; Calderaro J; Rebouissou S; Couchy G; Meiller C; Shinde J; Soysouvanh F; Calatayud AL; Pinyol R; Pelletier L; Balabaud C; Laurent A; Blanc JF; Mazzaferro V; Calvo F; Villanueva A; Nault JC; Bioulac-Sage P; Stratton MR; Llovet JM; Zucman-Rossi J
Nat Genet; 2015 May; 47(5):505-511. PubMed ID: 25822088
[TBL] [Abstract][Full Text] [Related]
20. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
